Acumen Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Acumen Pharmaceuticals, Inc.

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal a…

Biotechnology
US, Charlottesville [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Acumen Pharmaceuticals, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Acumen Pharmaceuticals, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Acumen Pharmaceuticals, Inc..

End of ABOS's Analysis
CIK: 1576885 CUSIP: 00509G209 ISIN: US00509G2093 LEI: - UEI: -
Secondary Listings
ABOS has no secondary listings inside our databases.